Abnormalities of Chromosome Bands 13q12 to 13q14 in Childhood Acute Lymphoblastic Leukemia
Nyla A. Heerema(The Ohio State University), Fatih M. Uckun(University of Southern California), Gregory H. Reaman(National Cancer Institute), Paul S. Gaynon(University of Southern California), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Mei K. Lee(Parker Hughes Cancer Center), James B. Nachman(University of Chicago), Harland N. Sather(Children's Oncology Group), Bruce Bostrom(Minnesota West Community & Technical College), Beverly J. Lange(Philadelphia University), Martha G. Sensel(Parker Hughes Cancer Center)
Cited by 30
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920